1-7 of 7
José-Francisco Tomás
Close
Sort by
Journal Articles

Predictive Value for Event-Free Survival of Interim 18F-FDG-PET In Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with 6 Cycles of Dose-Dense R-CHOP-14 Immunochemotherapy Plus Pegfilgrastim as First-Line Treatment: An Open-Label Clinical Trial In Spain.

Eva González-Barca, Miguel Canales, MD, PhD, María Jesús Vidal, Albert Oriol, Antonio Salar, Joan Bargay, Montse Cortés, Juan Coya, José Francisco Tomás, Andrés López, José Javier Sánchez, Eva Donato, Andrés Llorente, Secundino Ferrer, Dolores Caballero
Journal: Blood
Blood (2010) 116 (21): 2793.
https://doi.org/10.1182/blood.V116.21.2793.2793
Published: 2010
Journal Articles

Pharmacological Inhibition of PIM Kinases In Chronic Lymphocytic Leukemia Cases with Unfavorable Prognosis Markers

Beatriz Herreros, James R. Bischoff, Maria E. Rodriguez, Margarita Sanchez-Beato, Elena Domenech, Carmen Blanco, Cristina I. Gomez-Abad, Raul Cordoba, Julio Delgado, Jose A Garcia-Marco, MD, PhD, Juan F. Garcia, José Francisco Tomás, Joaquín Martínez-López, Antonia Rodriguez, Raquel Villuendas, Miguel A. Piris
Journal: Blood
Blood (2010) 116 (21): 2468.
https://doi.org/10.1182/blood.V116.21.2468.2468
Published: 2010
Journal Articles

Targeting the Apoptotic Pathway by TW-37, a Novel Bcl-2 Family Small Molecule Inhibitor, In CLL Primary Samples

Beatriz Herreros, Shaomeng Wang, Maria E. Rodriguez, Margarita Sanchez-Beato, Elena Domenech, Raul Cordoba, Julio Delgado, Jose A Garcia-Marco, MD, PhD, Juan F. Garcia, José Francisco Tomás, Joaquín Martínez-López, Jose Luis Bello, Antonia Rodriguez, Raquel Villuendas, Miguel A. Piris
Journal: Blood
Blood (2010) 116 (21): 2470.
https://doi.org/10.1182/blood.V116.21.2470.2470
Published: 2010
Journal Articles

Mirna EXPRESSION SIGNATURES as PROGNOSTIC Markers IN ADVANCED Classical HODGKIN LYMPHOMA

Beatriz Sanchez-Espiridion, Carlos Montalban ESQ, MD, PhD, Pablo Guisado, Maria E. Rodriguez, Miguel Canales, Javier Alves, Francisco Vega, MD, PhD, Manuel Morente, José Francisco Tomás, Miguel A. Piris, Juan F. Garcia
Journal: Blood
Blood (2010) 116 (21): 4157.
https://doi.org/10.1182/blood.V116.21.4157.4157
Published: 2010
Journal Articles

Long Term Results of Fludarabine/Melphalan as Reduced Intensity Conditioning Regimen (RIC) for Transplantation in Mantle Cell Lymphoma (MCL): Age Matters

Jorge Gayoso, Rodrigo Martino, Pascual Balsalobre, Javier De la Serna, José Francisco Tomás, Alberto Fernandez de Sevilla, David Serrano, Anna Sureda, Jorge Sierra, Jose L. Diez-Martin, Dolores Caballero
Journal: Blood
Blood (2008) 112 (11): 4388.
https://doi.org/10.1182/blood.V112.11.4388.4388
Published: 2008
Journal Articles

Incidence and Outcome of Hepatic Veno-Occlusive Disease After Blood or Marrow Transplantation: A Prospective Cohort Study of the European Group for Blood and Marrow Transplantation

Enric Carreras, Hartmut Bertz, William Arcese, Jean-Paul Vernant, José-Francisco Tomás, Hans Hagglund, Giuseppe Bandini, Hèléne Esperou, James Russell, Javier de la Rubia, Gabriele Di Girolamo, Hilde Demuynck, Olivier Hartmann, Johannes Clausen, Tapani Ruutu, Veronique Leblond, Arturo Iriondo, Alberto Bosi, Isaac Ben-Bassat, Vladimir Koza, Alois Gratwohl, Jane F. Apperley
Journal: Blood
Blood (1998) 92 (10): 3599–3604.
https://doi.org/10.1182/blood.V92.10.3599
Published: 1998
Journal Articles

Hepatitis C and G Virus Infection and Liver Dysfunction After Allogeneic Bone Marrow Transplantation: Results From a Prospective Study

Elena Rodriguez-Iñigo, José-Francisco Tomás, Valle Gómez-Garcı́a de Soria, Javier Bartolomé, Inmaculada Pinilla, Marı́a-José Amaro, Vicente Carreño, José-Marı́a Fernández-Rañada
Journal: Blood
Blood (1997) 90 (3): 1326–1331.
https://doi.org/10.1182/blood.V90.3.1326
Published: 1997